14 February

Nanomaterials, graphene and the immune cells: interactions and applications

Friday 14 February 2020, 11:00am

ICN2 Seminar Hall, ICN2 Building, UAB

Dr Lucia Gemma Delogu, Head of ImmuneNano-lab at the University of Padua, Italy

Abstract:  Graphene is a disruptive technology that is opening up new markets and even replacing existing technologies and materials thanks to its amazing chemical and physical properties. An ever-growing number of graphene-enhanced products are already commercially available. However, despite the large efforts and an impressive number of research projects funded in Europe and worldwide, a “killer application” of graphene is not yet universally recognized. What would happen if the future killer application of graphene arose from basic research and cell biology, the most unexpected field for this material?

The overall objective of our research group is to provide new insights on graphene immune interactions and identify highly biocompatible graphene-based nanomaterials with specific functionalizations. We here share published and unpublished data on different pictures of graphene and other nanomaterials e.g. from cancer therapy to bone regeneration.

We dream to transform the current approach of graphene and related materials production by shaping their chemical and physical parameters on the basis of intrinsic immune properties. By doing that, we aim at depicting a “Nanoimmunity by design” concept that can direct future biomedical applications and, on the other hand, boost a safe explosion in the market in Europe and worldwide. 

Hosted by Prof. Arben Merkoçi, Nanobioelectronics & Biosensors Group Leader at ICN2